Class / Patent application number | Description | Number of patent applications / Date published |
514772500 | Heterocyclic monomer | 42 |
20080262102 | Hydrophilic/Hydrophobic Polymer Networks Based on Poly(Caprolactone Fumarate), Poly(Ethylene Glycol Fumarate), and Copolymers Thereof - Improved methods for preparing polyethylene glycol fumarate) are disclosed. Methods for chemically crosslinking or photocross-linking hydrophilic polyethylene glycol fumarate) with hydrophobic polymers such as poly(propylene fumarate) (PPF) and poly(caprolactone fumarate) (PCLF) to form various hydrogels (FIG. | 10-23-2008 |
20090036550 | Copolymers Based on Polyalkylene Oxide-Modified N-Vinyl Lactam Copolymers - Vinyllactam copolymers modified with polyalkylene oxide side-chains, and use thereof as solubilizers for substances which are sparingly soluble in water, and preparations comprising such copolymers. | 02-05-2009 |
20090036551 | COPOLYMERS BASED ON N-VINYL LACTAMS AND OLEFINS AS THEIR USE AS SOLUBILIZERS FOR SLIGHTLY WATER-SOLUBLE COMPOUNDS - The use of copolymers obtained by free-radical polymerization of a mixture of | 02-05-2009 |
20090124707 | NONSPECIFIC ADSORPTION INHIBITOR OF SUBSTANCE RELATING TO LIVING BODY AND METHOD FOR COATING ARTICLE - a nonspecific adsorption inhibitor of a substance relating to a living body, which inhibits nonspecific adsorption of a substance relating to a living body such as various species of proteins which are used in clinical diagnostic agents, clinical diagnosis devices, biochips and the like, and a method for coating an article using said nonspecific adsorption inhibitor. | 05-14-2009 |
20090209661 | DELIVERY PARTICLE - The present application relates to agglomerates/particles comprising encapsulated, benefit agents, compositions comprising such agglomerates/particles, and processes for making and using such agglomerates/particles and compositions comprising such agglomerates/particles. Such agglomerates/particles are processed to a form that minimizes or eliminate certain drawbacks associated with incorporating encapsulated benefit agents in consumer products. | 08-20-2009 |
20090253807 | AQUEOUS SUSPENSION PREPARATIONS - Addition of polyvinylpyrrolidone and a water-soluble anionic macromolecular compound to an aqueous suspension of a hardly soluble drug allows to provide an aqueous suspension in which aggregation of drug particles, formation of macro crystals from suspended particles and formation of secondary particles from deposited particles are prevented, and adhesion and adsorption to containers made of plastics, e.g., polypropylene or polyethylene, are avoided. As it has a good redispersibility, the aqueous suspension is useful as eye drops, nasal drops, ear drops, injections, oral preparations, liniments and lotions. | 10-08-2009 |
20090312441 | ORGANIC COMPOUNDS - A solid pharmaceutical composition comprising a poorly water soluble drug, a polymer which is solid at room temperature, and a disintegrant in an amount of less than 10% by weight, wherein the amounts by weight are based on the total weight of the composition. | 12-17-2009 |
20090318568 | ADHERENT COATING FOR TISSUE SURFACE AND/OR TRANS-TISSUE SURFACE SUBSTANCE DELIVERY - An adherent coating composition is described having a reservoir of medication or other substance and capable of intimate contact with a target area of exposed tissue, rapid conveyance of the medication onto or into the target area. Mixtures of polyvinylpyrrolidone and glycerin have been found to dissolve a large number of medications while producing an adherent film. Application of the present composition to provide anti-cancer medication to exposed tissue resulting from tumor resection is also described. | 12-24-2009 |
20100004345 | HIGH GLOSS NON-STICK FILM COATING COMPOSITIONS - The invention generally relates to film coating compositions and processes for film coating pharmaceutical, nutraceutical, and food products. One film coating composition includes a shellac in an aqueous solution; a hydrolyzed starch product; an optional plasticizer; and a coating resin. The coating resin may be one or more of polyvinyl pyrrolidone, polyvinyl alcohol, and poly(vinyl pyrrolidone-vinyl acetate). The shellac, hydrolyzed starch product, plasticizer and coating resin comprise the solids in the composition. | 01-07-2010 |
20100048737 | COSMETIC PREPARATIONS BASED ON MOLECULARLY IMPRINTED POLYMERS - The present invention relates to cosmetic or dermatological formulations comprising at least one active compound, at least one polymer which is molecularly imprinted in the presence of this active compound and at least one fatty phase. | 02-25-2010 |
20100056647 | Copolymers useful as rheology modifiers and home and personal care compositions comprising said copolymers - The present invention relates to aqueous personal care, household care, and/or fabric care compositions comprising the instant copolymers. Also disclosed are methods for the rheological modification of aqueous personal care, household care, and/or fabric care compositions comprising the instant copolymers. | 03-04-2010 |
20100063167 | Agrochemical Formulations Comprising Co-Polymers Based on Ethylenically Unsaturated Dicarboxylic Mono and Diesters - The present invention comprises the use of formulations comprising at least one pesticide and at least one co-polymer comprising (a) at least one comonomer (a) selected from the group consisting of olefins, vinylethers, vinyl pyrrolidone and styrene; and (b) at least one comonomer (b) selected from the group consisting of ethylenically unsaturated dicarboxylic mono and diesters, wherein the alcohol moiety of the mono- or diester has the structure of formula I wherein R | 03-11-2010 |
20100137455 | N-VINYLCAPROLACTAM-BASED COPOLYMERS AND THE USE THEREOF AS SOLUBILIZERS - Copolymers for use in solubilizing substances which are insoluble in water, substances which are only sparingly soluble in water, and combinations thereof; such copolymers comprising: (a) 60 to 99% by weight of N-vinylcaprolactam; and (b) 1 to 40% by weight of at least one other monomer selected from the group consisting of: C | 06-03-2010 |
20100240773 | MULTIFUNCTIONAL LINKERS - The present invention relates generally to multifunctional polymeric linkers capable of linking a plurality of biologically active compounds. More particularly, the invention relates to the use of such multifunctional linkers that can effectively present two or more ligands simultaneously to two or more biological targets. | 09-23-2010 |
20110015280 | AMPHOLYTIC COPOLYMER, PRODUCTION THEREOF, AND USE OF THE SAME - The present invention relates to an ampholytic copolymer, to a process for its preparation, to cosmetic or pharmaceutical compositions which comprise at least one such ampholytic copolymer, and to further uses of these copolymers. | 01-20-2011 |
20110178183 | Use Of Polyether-Based And Vinyl Monomer-Based Copolymers As Binders For Dosing Forms Comprising Solid Active Ingredients - The use of water-soluble or water-dispersible copolymers which are obtained by free radical-initiated polymerization of a mixture of
| 07-21-2011 |
20120029089 | PREPARING BIODEGRADABLE HYDROGEL FOR BIOMEDICAL APPLICATION - Biodegradable dextran based hydrogel suitable for biomedical application is produced by subjecting polysaccharide substituted with unsaturated moiety, e.g. dextran methacrylate, in aqueous medium to UV or visible light irradiation in the precense of riboflavin/L-arginine or riboflavin/chitosan to cause photocrosslinking of polysaccharide substituted with unsaturated moiety. | 02-02-2012 |
20120095110 | BRANCHED POLYMER DISPERSANTS - The present invention relates to the use of a branched addition copolymer as a dispersant in a gaseous, liquid or solid formulation in a range of applications and to the copolymers per se wherein the copolymer is obtainable by an addition polymerisation process, wherein said copolymer comprises: at least two chains which are covalently linked by a bridge other than at their ends; and wherein the at least two chains comprise at least one ethylenically monounsaturated monomer, and wherein the bridge comprises at least one ethylenically polyunsaturated monomer; and wherein the polymer comprises a residue of a chain transfer agent and wherein the mole ratio of polyunsaturated monomer(s) to monounsaturated monomer(s) is in a range of from 1:100 to 1:4; and wherein the branched copolymer dispersant contains anchoring, solubilising or stabilising moieties and wherein the resulting copolymer has a weight average molecular weight of less than 100,000 Da. | 04-19-2012 |
20120095111 | BRANCHED POLYMER DISPERSANTS - The present invention relates to the use of a branched addition copolymer as a dispersant in a gaseous, liquid or solid formulation in a range of applications and branched addition copolymers suitable for same wherein the copolymer is obtainable by an addition polymerisation process, wherein said copolymer comprises: at least two chains which are covalently linked by a bridge other than at their ends; and wherein the at least two chains comprise at least one ethyleneically monounsaturated monomer, and wherein the bridge comprises at least one ethyleneically polyunsaturated monomer; and wherein the polymer comprises a residue of a chain transfer agent and wherein the mole ratio of polyunsaturated monomer(s) to monounsaturated monomer(s) is in a range of from 1:100 to 1:4; and wherein the branched copolymer dispersant contains anchoring, solubilising or stabilising moieties and wherein the resulting copolymer comprises at least 10% styrenic monomer, brancher or chain transfer agent. | 04-19-2012 |
20120095112 | BRANCHED POLYMER DISPERSANTS - The present invention relates to the use of a branched addition copolymer as a dispersant in a gaseous, liquid or solid formulation in a range of applications and to the copolymers per se wherein the copolymer is obtainable by an addition polymerisation process, wherein said copolymer comprises: at least two chains which are covalently linked by a bridge other than at their ends; and wherein the at least two chains comprise at least one ethyleneically monounsaturated monomer, and wherein the bridge comprises at least one ethyleneically polyunsaturated monomer; and wherein the polymer comprises a residue of a chain transfer agent and wherein the mole ratio of polyunsaturated monomer(s) to monounsaturated monomer(s) is in a range of from 1:100 to 1:4; and wherein the branched copolymer dispersant contains anchoring, solubilising or stabilising moieties and wherein the resulting copolymer has a weight average molecular weight of greater than 100,000 Da. | 04-19-2012 |
20120108678 | BRANCHED COPOLYMERS, COMPOSITIONS AND USES - The present invention relates to a branched copolymer obtainable by an addition polymerisation process and uses and compositions thereof comprising:
| 05-03-2012 |
20120115963 | POLYMER NANOPARTICLES - A process for the preparation of a polymer nanoparticle by a photoinduced emulsion polymerization includes preparing an emulsion comprising at least one surfactant, a dispersed phase and a continuous phase. The dispersed phase comprises at least one polymerizable monomer and the continuous phase comprises water and at least one photoinitiator. The at least one polymerizable monomer is polymerized by exposing the emulsion to an electromagnetic radiation having a wavelength so as to induce a generation of radicals from the at least one photoinitiator. The at least one photoinitiator is selected from at least one compound of formula (I) | 05-10-2012 |
20120202896 | COMPOSITION INCLUDING A COPOLYAMIDE AND A CROSS-LINKED POLYOLEFIN - The invention relates to a composition including: 45 to 95 wt % of a semi-aromatic copolyamide containing at least two separate units having the following general formulation: A/X.T, where A is selected from among a unit obtained from an amino acid, a unit obtained from a lactam, and a twit having the formula (diamine Ca).(diacid Cb), and XT denotes a unit obtained from the polycondensation of a diamine in Cx and from terephthalic acid, with x being the number of carbon atoms of the diamine in Cx, said copolyamide having a polymoleoularity index, noted Ip, of less than or equal to 3.5, measured by gel permeation chromatography, and an amino chain end content of between 0.020 mcg/g and 0.058 mcg/g; and 5 to 55 wt % of at least one cross-linked polyolefin. The invention also relates to a method for preparing said composition and to the uses thereof. | 08-09-2012 |
20120225953 | Self-Emulsifying Active Ingredient Formulation and the Use of this Formulation - The present invention relates to self-emulsifying formulations based on an active ingredient component and a formulation base with a lipid component and with a binder component and to the use of this formulation as dosage form in the life science sector. The invention also describes a process for producing self-emulsifying formulations by mixing the formulation components to form a plastic mixture and, where appropriate, to manufacture the formulations as dosage form advantageously by use of melt extrusion. The formulations spontaneously form emulsions in water or aqueous media. | 09-06-2012 |
20130059927 | Emulsions of Polyisobutenes, Substance and Process - The present invention is directed to stable emulsions comprising polyolefins, in particular polyisobutene, the process to obtain said emulsions and the use of said emulsions. | 03-07-2013 |
20130085186 | COSMETIC PREPARATIONS BASED ON MOLECULARLY IMPRINTED POLYMERS - The present invention relates to cosmetic or dermatological formulations comprising at least one active compound, at least one polymer which is molecularly imprinted in the presence of this active compound and at least one fatty phase. | 04-04-2013 |
20130137781 | PHARMACEUTICAL PREPARATION FOR CONTROLLING WATER-SOLUBLE DRUG RELEASE - A solid formulation comprising a water-soluble drug and a hardly water-soluble pharmaceutically-acceptable solid substance, which comprises silicone as a carrier, wherein the silicone formulation can exhibit an excellent controlled-release of the water-soluble drug. | 05-30-2013 |
20130190409 | DRUG DELIVERY VEHICLES, METHODS OF MANUFACTURE, AND METHODS OF USE THEREOF - Drug delivery vehicles that release one or more drugs, e.g., an opioid antagonist and/or an opioid, in response to changes in the chemistry of body fluids, specifically in response to changes in the partial pressure of CO | 07-25-2013 |
20130197100 | COLLOIDAL NANOSCALE CARRIERS FOR ACTIVE HYDROPHILIC SUBSTANCES AND METHOD FOR PRODUCING SAME - The invention “colloidal nanoscale carriers for active hydrophilic substances and method for producing same” pertains to the field of medical, odontological or hygiene preparations, and is characterized by structures formed by hydrophilic polymers that contain active hydrophilic substances coated with a non-hydrophilic phase and surfactants with affinity for the components, forming an invert emulsion that allows the incorporation and controlled delivery of active hydrophilic substances, conferring properties such as protection against degradation processes, improvement of compatibility with the other components of the formulation in the final product, increase in the availability and/or bioavailability of the active substance in the medium of interest (including improvements in permeation processes in biological materials, reduction of the exposure and volatilization of the active substance in the medium) and controlled release of the active substance(s). The nanoscale carrier obtained by this method, called colloidal nanoscale carrier (NC), can be used in various fields, such as the pharmaceutical field (including dermatology), cosmetics, personal hygiene products, veterinary medicine, agrochemicals and fertilizers, the food industry and the like. The invention proposes a kinetically stable system with an effective nanoscale structure that consists of nanoscale carriers formed by polymers emulsified in a non-aqueous medium in the presence of a surfactant with affinity for the two phases (the dispersion medium and the encapsulating agent). This system is obtained by nanoemulsification of an aqueous phase of hydrophilic polymers emulsified in a non-hydrophilic (lipophilic or silophilic) phase that contains the surfactants, and is characterized by the implementation of two concepts that encompass the generation of an invert nanoscale emulsion and of polymer nanoparticles. The formulation has the novel technical effect of providing a polymer excipient with a nanoscale structure for delivering hydrophilic molecules suspended in a non-hydrophilic phase, which allows controlling the size of the nanoscale particles and modulating colloidal stability by means of process parameters. | 08-01-2013 |
20130281546 | INTRABUCCALLY RAPIDLY DISINTEGRATING TABLET AND A PRODUCTION METHOD OF THE TABLETS - An intrabuccally rapidly disintegrating tablet which is manufactured by a simple method, has an enough practical hardness and is rapidly disintegrated in the buccal cavity and its production method. The intrabuccally rapidly disintegrating tablet is produced by growing a powder material into a granulated material with a fixed particle diameter, the powder material including a sugar alcohol or a saccharide as main ingredient, each of which is first particle having an average particle diameter of not more than 30 μm, by mixing thus obtained granulated material with an active ingredient and a disintegrant, and by compressing the mixture into a predetermined shape. | 10-24-2013 |
20130303630 | Thermo-Kinetic Mixing for Pharmaceutical Applications - Compositions and methods for making a pharmaceutical dosage form include making a pharmaceutical composition that includes one or more active pharmaceutical ingredients (API) with one or more pharmaceutically acceptable excipients by thermokinetic compounding into a composite. Compositions and methods of preprocessing a composite comprising one or more APIs with one or more excipients include thermokinetic compounding, comprising thermokinetic processing the APIs with the excipients into a composite, wherein the composite can be further processed by conventional methods known in the art, such as hot melt extrusion, melt granulation, compression molding, tablet compression, capsule filling, film-coating, or injection molding. | 11-14-2013 |
20140107226 | METHODS FOR ENHANCING STABILITY OF POLYORTHOESTERS AND THEIR FORMULATIONS - Disclosed herein are methods of enhancing the stability of a sustained pharmaceutical composition comprising an active agent and a polymer and methods of preparing such pharmaceutical compositions with enhanced stability. | 04-17-2014 |
20140155495 | TRANSDERMAL DELIVERY PATCH - A composition suitable for use in a transdermal delivery patch for administration of a biologically active compound, the composition comprising a phosphate compound of tocopherol and a polymer carrier. | 06-05-2014 |
20140194535 | ANHYDROUS EMULSIONS CONTAINING POLYLYSINE AND POLAR MODIFIED POLYMER - The present invention generally relates to anhydrous emulsions containing an oil-soluble polar modified polymer and polylysine. | 07-10-2014 |
20140200278 | PHARMACEUTICAL DOSAGE FORM COMPRISING POLYMERIC CARRIER COMPOSITION - A pharmaceutical dosage form comprises a solid dispersion product of at least one active ingredient dispersed in a polymeric binder composition, the polymeric carrier composition comprising a) a vinylpyrrolidone homopolymer, wherein at least 95% by weight of the vinylpyrrolidone homopolymer has a molecular weight distribution within the range of from 1000 to 13 000; and b) a vinylpyrrolidone copolymer having a weight-average molecular weight of from 5000 to 1 500 000. The dosage form is preferably prepared by a melt extrusion process. The polymeric carrier composition exhibits a high drug dissolution power and allows a reduction of the viscosity of the melt without deteriorating the mechanical properties and storage stability of the dosage form. | 07-17-2014 |
20140213662 | PARTICLES WITH DESIGNED DIFFERENT SIZED DISCRETE PORES - Polymeric porous particles have a continuous solid phase and at least two sets of discrete pores that are isolated from each other within the continuous phase and that have different average sizes. One set of discrete pores has a larger average size than another set of discrete pores by at least 50%. At least one set of discrete pores is free of detectably different marker materials. There porous particles can be prepared using evaporative limited coalescence techniques with especially chosen discrete pore stabilizing hydrocolloids to protect the pores during formation and to provide the different average sizes. | 07-31-2014 |
20150011657 | Live poly(n-vinyl lactam) reactive stabilizers for dispersed phase polymerization - The present invention concerns a method for preparing a polymer comprising a step (EI) for dispersed phase polymerization in the presence of a reactive stabiliser, wherein the following are brought into contact in an aqueous phase:—at least one ethylenically unsaturated monomer;—at least one source of free radicals; and—a reactive stabiliser comprising a polymer chain including monomer units (N-vinyl lactam) and a thiocarbonylthio-S group (C═S)—. | 01-08-2015 |
20150045452 | METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE - The present application provides an orally-disintegrating tablet having excellent tablet hardness and disintegrability. The present application further provides a method of producing a disintegrative particulate composition including three components consisting of a first disintegrator component of an acid-type carboxymethylcellulose, a second disintegrator component and an excipient. The method includes a first wet granulation step using any two of the three components, and a second wet granulation step using granules obtained in the first wet granulation step and the remaining one component of the three components not used in the first wet granulation step. The production method may further includes a crystalline cellulose as a fourth component or a third step of mixing a crystalline cellulose into granules obtained in the second wet granulation step. Disintegrative particulate compositions obtained by these methods are also disclosed. | 02-12-2015 |
20150148431 | TRANSDERMAL DELIVERY PATCH - A composition suitable for use in a transdermal delivery patch for administration of a biologically active compound, the composition comprising a phosphate compound of tocopherol and a polymer carrier. | 05-28-2015 |
20150342860 | IRRITATION MITIGATING POLYMERS AND USES THEREFOR - The present invention provides mild cleansing and cleaning compositions and methods for mitigating irritation induced by harsh detersive surfactants. The invention relates to a method of reducing skin irritation associated with a cleansing composition comprising at least one surfactant, the method comprising combining an effective amount of at least one nonionic amphiphilic polymer with at least one detersive surfactant selected from anionic surfactants, amphoteric surfactants, nonionic surfactants and combinations of two or more thereof. The at least one nonionic amphiphilic irritation mitigating polymer is prepared from a free radically polymerizable monomer composition comprising at least one hydrophilic monomer and at least one hydrophobic monomer, wherein said N-vinyl lactam and wherein said hydrophobic monomer is selected from a vinyl ester of a C | 12-03-2015 |
20160120984 | SUGAR CONTAINING, AMPHIPHILIC COPOLYMERS - Disclosed herein are polymers made from at least one monomer of formulae (I), (II), (III), and (IV), in combination with a monomer of formula (V) that may be used in pharmaceutical formulations. These polymers comprise a hydrocarbon backbone and are made from monomers that contain at least one carbon-carbon double bond. Methods of making these polymers are also disclosed. | 05-05-2016 |
20160250335 | FAST DISINTEGRATING COMPOSITIONS AND TABLETS THEREOF | 09-01-2016 |